ANNX.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (13 May 2024 @ 11:18):

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. The company develops ANXV, a human recombinant protein...

Stats
Today's Volume	372 596
Average Volume	263 518
Market Cap	166.47M
EPS	SEK-0.0700 ( 2023-09-30 )
Next earnings date	( SEK0 ) 2024-05-24
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.440
ATR14	SEK0.00400 (1.27%)

Annexin Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Annexin Pharmaceuticals Financials

Annual	2023
Revenue:	SEK0
Gross Profit:	SEK-193 000 (0.00 %)
EPS:	SEK-0.250

FY	2023
Revenue:	SEK0
Gross Profit:	SEK-193 000 (0.00 %)
EPS:	SEK-0.250

FY	2022
Revenue:	SEK0
Gross Profit:	SEK-193 000 (0.00 %)
EPS:	SEK-0.170

FY	2021
Revenue:	SEK0.00
Gross Profit:	SEK0.00 (0.00 %)
EPS:	SEK-0.569

Financial Reports:

No articles found.

Annexin Pharmaceuticals

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. The company develops ANXV, a human recombinant protein. It offers Annexin A5 to protect and repair blood vessels and counteract inflammation. The company was founded in 2014 and is based in Stockholm, Sweden.